On the other hand, Wegovy contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist
Glucagon-like peptide-1 receptor agonists might be disease-modifying in patients with knee osteoarthritis and type 2 diabetes if treatment is sustained for a sufficient period, according to data
Key determinants of success in fecal microbiota transplantation: from microbiome to clinic
W.WangJ.RenQ
Other GLP-/GIP medications, including Wegovy (tirzepatide), Ozempic (tirzepatide), Saxenda (liraglutide), Zepbound (tirzepatide), Mounjaro (tirzepatide), Victoza (liraglutide), Byetta (exenatide), or Bydureon (exenatide).If youre using other products for weight loss, including dietary supplements